Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Osteotech has entered into a three-year agreement with Harvest Technologies to distribute the Bone Marrow Aspirate Concentrate System.
Subscribe to our email newsletter
Under the agreement, Osteotech has the exclusive right to distribute the Bone Marrow Aspirate Concentrate (BMAC) System for bone regeneration in orthopedic and spinal surgical procedures in most of the US.
The BMAC System, developed and manufactured by Harvest, is said to be the first ‘point-of-care’ platform that makes possible the use of a clinically significant quantity of cellular compositions from a small aspirate of bone marrow. The BMAC System derives bone marrow aspirate concentrate, which is a rich source of autologous adult stem cells, in just 15 minutes.
Sam Owusu-Akyaw, Osteotech’s president and CEO, said: “We expect to begin to distribute the BMAC System before the end of the second quarter of 2008. We are currently putting the finishing touches on our roll-out plan and will begin training our sales team shortly.”